Human T cells belonging to cancer patients arrive at Novartis Pharmaceuticals Corp.’s Morris Plains, N.J., facility. The California Legislature is debating a bill on drug price transparency opposed by biopharmaceutical companies.
Human T cells belonging to cancer patients arrive at Novartis Pharmaceuticals Corp.’s Morris Plains, N.J., facility. The California Legislature is debating a bill on drug price transparency opposed by biopharmaceutical companies. Brent Stirton Novartis Pharmaceuticals Corp. via AP
Human T cells belonging to cancer patients arrive at Novartis Pharmaceuticals Corp.’s Morris Plains, N.J., facility. The California Legislature is debating a bill on drug price transparency opposed by biopharmaceutical companies. Brent Stirton Novartis Pharmaceuticals Corp. via AP